Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injury

Developmental Neuroscience

Volumn 24, Issue 5, 2002, Pages 405-410

  Hee Han, Byung ^a,b   Choi, Junjeong ^b   Holtzman, David M ^b,c,d,e  

^a Ewha Womans University   (South Korea)

^b Department of Neurology ^*  (United States)

^c Ctr for the Study of Nerv Syst I   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Caspase 3; Hypoxia ischemia; Mitogen activated protein kinase; Neurodegeneration; Neuroprotection; p38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TREATMENT FAILURE;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CASPASE 3; CASPASES; ENZYME INHIBITORS; HYPOXIA-ISCHEMIA, BRAIN; IMIDAZOLES; INJECTIONS, INTRAVENTRICULAR; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036954301     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069046     Document Type: Conference Paper

References (37)

1. Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM, Holtzman DM (2000): BDNF protects. Against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol 166:99-114.
2. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, White RF, McVey MJ, Legos JJ, Erhardt JA, Nelson AH, Ohlstein EH, Hunter AJ, Ward K, Smith BR, Adams JL, Parsons AA (2001): SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther 296:312-321.
3. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C, Hagberg H (2001): Synergistic activation of caspase-3 by m-cal-pain after neonatal hypoxia-ischemia: A mechanism of 'pathological apoptosis'? J Biol Chem 276:10191-10198.
4. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999): Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362.
5. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM (1998): Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 101:1992-1999.
6. Ferriero DM, Arcavi LJ, Sagar SM, McIntosh TK, Simon RP (1988): Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia-ischemia. Ann Neurol 24:670-676.
7. Han BH, D'Costa A, Back SA, Parsadanian M, Patel S, Shah AR, Gidday JM, Srinivasan A, Deshmukh M, Holtzman DM (2000): BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 7:38-53.
8. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, Fryer JD, Kierson M, Cirrito J, Quick K, Harmony JA, Aronow BJ, Holtzman DM (2001): Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7:338-343.
9. Han BH, Holtzman DM (2000): BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 20:5775-5781.
10. Han BH, Xu D, Choi J, Han Y, Xanthoudakis S, Roy S, Tam J, Vaillancourt J, Colucci J, Siman R, Giroux A, Robertson GS, Zamboni R, Nicholson DW, Holtzman DM (2002): Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 277:30128-30136.
11. Harper SJ, LoGrasso P (2001): Signalling for survival and death in neurones: The role of stress-activated kinases, JNK and p38. Cell Signal 13:299-310.
12. Hayashi T, Sakai K, Sasaki C, Zhang WR, Warita H, Abe K (2000): c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neurosci Lett 284:195-199.
13. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H (2002): Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 22:5910-5919.
14. Hu BR, Liu CL, Park DJ (2000): Alteration of MAP kinase pathways after transient forebrain ischemia. J Cereb Blood Flow Metab 20:1089-1095.
15. Irving EA, Bamford M (2002): Role of mitogen-and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
16. Johnston MV (1983): Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann Neurol 13:511-518.
17. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E (1997): Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272: 18518-18521.
18. Kummer JL, Rao PK, Heidenreich KA (1997): Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J Biol Chem 272:20490-20494.
19. Kyriakis JM, Avruch J (2001): Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
20. Legos JJ, Erhardt JA, White RF, Lenhard SC, Chandra S, Parsons AA, Tuma RF, Barone FC (2001): SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res 892:70-77.
21. Levine S (1960): Anoxic-ischemic encephalopathy in rats. Am J Pathol 36:1-17.
22. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1995): Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481-1488.
23. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feurestein GZ (1993): Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke 24:1746-1751.
24. Martin-Blanco E (2000): p38 MAPK signalling cascades: Ancient roles and new functions. Bioessays 22:637-645.
25. Mielke K, Herdegen T (2000): JNK and p38 stress-kinases - degenerative effectors of signal- trans-duction-cascades in the nervous system. Prog Neurobiol 61:45-60.
26. Nebreda AR, Porras A (2000): p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 25:257-260.
27. Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ (2001): Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 8:207-219.
28. Olney JW, Ikonomidou C, Mosinger JL, Frierdich G (1989): MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9:1701-1704.
29. Paxinos G, Watson C (1986): The Rat Brain in Stereotaxic Coordinates, ed 2. York, Academic Press
30. Perregaux DG, Dean D, Cronan M, Connelly P, Gabel CA (1995): Inhibition of interleukin-1 beta production by SKF86002: Evidence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol 48:433-442.
31. Rice JE, Vannucci RC, Brierley JB (1981): The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141.
32. Robinson MJ, Cobb MH (1997): Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186.
33. Towfighi J, Zec N, Yager J, Housman C, Vannucci RC (1995): Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: A light microscopic study. Acta Neuropathol 90:375-386.
34. Vannucci RC (1990): Experimental biology of cerebral hypoxia-ischemia: Relation to perinatal brain damage. Pediatr Res 27:317-326.
35. Volpe JJ (1995): Neurology of the Newborn, ed 3. Philadelphia, Saunders
36. Xia X, Dickens M, Raingeaud J, Davis R, Greenberg M (1995): Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
37. Yamashima T (2000): Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62:273-295.